Ca 2+ -Activated K + Channel K Ca 3.1 as a Double-Edged Sword in the Treatment of Inflammatory Bowel Disease

Authors

  • Susumu Ohya Department of Pharmacology, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan
  • Miki Matsui Department of Pharmacology, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan
  • Junko Kajikuri Department of Pharmacology, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan

DOI:

https://doi.org/10.15403/jgld-3234

Keywords:

KCa3.1, Inflammatory bowel disease, epithelial barrier function

Downloads

Published

2020-12-12

How to Cite

1.
Ohya S, Matsui M, Kajikuri J. Ca 2+ -Activated K + Channel K Ca 3.1 as a Double-Edged Sword in the Treatment of Inflammatory Bowel Disease. JGLD [Internet]. 2020 Dec. 12 [cited 2025 Jul. 15];29(4):487-9. Available from: https://jgld.ro/jgld/index.php/jgld/article/view/3234

Issue

Vol. 29 No. 4: December 2020

Section

Editorial